These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27811553)

  • 1. Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia.
    Li Q; Chen D; Liu T; Walss-Bass C; de Quevedo JL; Soares JC; Zhao J; Zhang XY
    J Clin Psychopharmacol; 2016 Dec; 36(6):643-648. PubMed ID: 27811553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits.
    Tian Y; Liu D; Wang D; Wang J; Xu H; Dai Q; Andriescue EC; Wu HE; Xiu M; Chen D; Wang L; Chen Y; Yang R; Wu A; Wei CW; Zhang X
    Schizophr Res; 2020 Jan; 215():270-276. PubMed ID: 31653580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.
    Yang F; Wang K; Du X; Deng H; Wu HE; Yin G; Ning Y; Huang X; Teixeira AL; de Quevedo J; Soares JC; Li X; Lang X; Zhang XY
    Psychopharmacology (Berl); 2019 Feb; 236(2):753-762. PubMed ID: 30456540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia.
    Li Q; Du X; Zhang Y; Yin G; Zhang G; Walss-Bass C; Quevedo J; Soares JC; Xia H; Li X; Zheng Y; Ning Y; Zhang XY
    Psychiatry Res; 2017 May; 251():131-136. PubMed ID: 28199911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls.
    Tian Y; Wang D; Wei G; Wang J; Zhou H; Xu H; Dai Q; Xiu M; Chen D; Wang L; Zhang XY
    Psychopharmacology (Berl); 2021 Mar; 238(3):745-753. PubMed ID: 33241480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, obesity, and psychopathology in patients with schizophrenia.
    Subramaniam M; Lam M; Guo ME; He VY; Lee J; Verma S; Chong SA
    J Clin Psychopharmacol; 2014 Feb; 34(1):40-6. PubMed ID: 24346756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome among inpatients with schizophrenia.
    Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR
    Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between vaspin and PANSS scores in schizophrenia patients with obesity.
    Ertekin H; Uysal S; Aydın M; İlhan B; Ertekin YH
    Int J Psychiatry Med; 2020 Jul; 55(4):264-280. PubMed ID: 32050814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity in multiracial schizophrenia patients receiving outpatient treatment in a regional tertiary hospital in malaysia.
    Norlelawati AT; Kartini A; Ramli M; Norsidah K; Wan Azizi WS; Tariq AR
    East Asian Arch Psychiatry; 2012 Jun; 22(2):49-56. PubMed ID: 22714874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Obesity and Cognitive Function in Chinese Elderly Patients With Chronic Schizophrenia.
    Li W; Lin S; Yue L; Fang Y; Xiao S
    Front Endocrinol (Lausanne); 2022; 13():742474. PubMed ID: 35432207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
    Ono S; Sugai T; Suzuki Y; Yamazaki M; Shimoda K; Mori T; Ozeki Y; Matsuda H; Sugawara N; Yasui-Furukori N; Okamoto K; Sagae T; Someya T
    BMC Psychiatry; 2018 Jun; 18(1):180. PubMed ID: 29879941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free Fatty acids and glucose metabolism, insulin resistance in schizophrenia with chronic antipsychotics.
    Wang CJ; Zhang ZJ; Sun J; Zhang XB; Mou XD; Zhang XR; Shang XF; Zhang TQ
    Biol Psychiatry; 2006 Dec; 60(12):1309-13. PubMed ID: 16650386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
    Chen S; Guo X; Zhang X; Yu S; Yang H; Jiang M; Sun G; Sun Y
    BMC Cardiovasc Disord; 2015 Jul; 15():65. PubMed ID: 26160405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.
    An H; Du X; Huang X; Qi L; Jia Q; Yin G; Xiao C; Huang XF; Ning Y; Cassidy RM; Wang L; Soares JC; Zhang XY
    Transl Psychiatry; 2018 Nov; 8(1):258. PubMed ID: 30498208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.
    Bressington D; Mui J; Tse ML; Gray R; Cheung EF; Chien WT
    BMC Psychiatry; 2016 Nov; 16(1):411. PubMed ID: 27863522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.